Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses ...
News Medical on MSN14h
Gastrolyzer® Range joins Selig De Colombia Portfolio, Expanding Access to Cutting-Edge Hydrogen Methane Breath Testing (HMBT) TechnologyBedfont ® Scientific Limited partners with Selig De Colombia to bring the Gastrolyzer® range of HMBT devices to Colombia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback